Data-driven stock analysis, valuation deep dives, and financial forensics. Every article backed by the numbers.
Iran's ceasefire rejection accelerates an already powerful rearmament cycle. With a $200 billion backlog and 25% revenue growth over four years, RTX is positioned for sustained expansion.
With 57.7% operating margins, $15 billion in net income, and a network moat that has defeated every fintech challenger, Mastercard at 25x forward earnings is a premium compounder at a fair price.
At sub-2x price-to-sales with $6.4 billion in free cash flow, Nike is priced for permanent decline. A 300 basis point margin recovery delivers 35-40% upside without any revenue growth.
JPMorgan offers fortress-grade defence at 13.7x forward, Goldman Sachs rides capital markets momentum after an 89% surge, and Bank of America bets on rate sensitivity.
At $4.3 trillion and 36x earnings, the market is pricing perfection — while tariff escalations threaten 17% of data centre revenue and the entire supply chain runs through Taiwan.
Foundayo's FDA approval transforms Eli Lilly from an injectable GLP-1 leader into an oral mass-market platform, with revenue already at $65.2 billion and accelerating.
Uber at 15.2x earnings with $9.8 billion in FCF versus Shopify at a premium growth multiple. Both are platform businesses — but only one offers compelling value today.
Revenue of $7.2 billion, free cash flow of $2.4 billion, and a subscription revenue mix approaching 50%. Coinbase at 38.4x earnings is not a crypto bet — it is a financial infrastructure play.
At 23.4x trailing earnings with $71.6 billion in FCF, Microsoft looks like a fortress. Five underappreciated risks suggest the margin of safety is thinner than it appears.
BHP, Vale, and Freeport-McMoRan each offer a distinct thesis on the commodity cycle. One stands out as the clear opportunity.
At 239x trailing earnings, Palantir looks indefensible. One chart — the operating leverage curve — tells you why the market keeps paying up.
SoFi just posted its first full year of profitability with $500 million in net income. The bulls are celebrating. They should be worried.
The world's largest healthcare company by revenue just posted a 2.7% profit margin on $447.6 billion in revenue. The Optum story is strong — but the insurance side is under pressure.
At 52.9x trailing earnings with a 3% profit margin, Costco looks absurdly overvalued. Four structural factors explain why the premium is not just justified — it may be too low.
Visa at 28.2x and Mastercard at 29.9x trailing earnings — two near-identical business models with a persistent valuation gap. The winner is clearer than the market thinks.